EML4 and lung adenocarcinoma: Alternatively, detecting the presence of the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion gene, termed the ALK-rearrangement, is routinely performed in lung adenocarcinomas and allows the treatment of such patients with anti-ALK targeted therapy.